CC

Claritev Corporation

CTEVยทNYSE

$27.75

-2.1%
HealthcareMedical - Healthcare Information Services

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.

At a Glance

Live Snapshot
Market Cap$473.08M
EPS-17.3000
P/E Ratio-1.60
Earnings Date08/05/2026
3Y-34.0%
5Y-41.0%
10Y-42.0%
3Y-9.0%
5Y-12.0%
10Y-21.0%
3Y-109.0%
5Y-107.0%
10Y-108.0%
c

Claritev Corporation Funding & Solvency Profile

CTEV ยท NYSE
Cash & Cash Equivalents16.81M
Net Receivables138.18M
Inventory0.00
Other Current Assets69.38M
Total Current Assets224 M
Property, Plant & Equipment340.29M
Goodwill & Intangible Assets4.29B
Long-Term Investments0.00
Other Non-Current Assets33.34M
Total Non-Current Assets374 M
Total Assets
4.89B

Financial Health Analysis

Current Ratio

0.86x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Working Capital

-36991000

Negative working capital indicates short-term liabilities exceed short-term assetsโ€”potential liquidity stress.

Asset Composition

5% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Claritev Corporation Balance Sheet

CTEV โ€ข NYSE

Claritev Corporation Balance SheetDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
ASSETS
CURRENT ASSETS
16.8M
16.8M
71.5M
334M
185.3M
126.8M
21.8M
16.8M
16.8M
71.5M
334M
185.3M
126.8M
21.8M
138.2M
111.6M
84.8M
78.9M
99.9M
63.2M
77.1M
138.2M
89.8M
76.6M
78.9M
99.9M
63.2M
77.1M
0.0
21.9M
8.2M
0.0
0.0
0.0
0.0
0.0
27.2M
24.8M
23.6M
30M
17.7M
16.5M
69.4M
19.8M
12.5M
10.2M
4.1M
1.2M
195K
224.4M
175.5M
193.6M
446.7M
319.3M
208.9M
115.6M
NON-CURRENT ASSETS
340.3M
308.7M
287.1M
257.1M
243.3M
219M
208M
2.4B
2.4B
3.8B
3.7B
4.4B
4.3B
4.1B
1.9B
2.2B
2.6B
2.9B
3.3B
3.6B
3.9B
4.3B
4.6B
6.5B
6.6B
7.6B
7.8B
8B
0.0
15M
0.0
0.0
0.0
0.0
0.0
33.3M
22.1M
21.8M
21.9M
9.7M
14.2M
8.2M
4.7B
5B
6.8B
6.9B
7.9B
8.1B
8.2B
4.9B
5.2B
7B
7.4B
8.2B
8.3B
8.4B
LIABILITIES
CURRENT LIABILITIES
60.5M
86.3M
19.6M
13.3M
13M
25.4M
9.9M
60.5M
86.3M
19.6M
13.3M
13M
15.3M
9.6M
0.0
0.0
0.0
0.0
0.0
10.2M
382K
0.0
76.1M
84.4M
108.4M
83.4M
58.8M
40M
19.4M
13.3M
13.3M
13.3M
13.3M
0.0
0.0
0.0
4.4M
4.8M
6.4M
6.9M
6.4M
9.5M
0.0
0.0
0.0
0.0
0.0
10.2M
382K
181.5M
33.7M
44.7M
34.6M
25.4M
21.8M
26.3M
261.4M
213.8M
166.7M
175.8M
141.9M
112.5M
85.8M
NON-CURRENT LIABILITIES
4.6B
4.5B
4.5B
4.7B
4.9B
4.6B
5.4B
197.6M
325.8M
521.7M
639.5M
753.8M
900.6M
869.2M
-16.2M
3.6M
17.3M
2.5M
74.1M
106.6M
0.0
4.8B
4.9B
5.1B
5.4B
5.7B
5.6B
6.3B
16.2M
18.2M
21.9M
27.3M
33.6M
34M
32.7M
5.1B
5.1B
5.3B
5.6B
5.9B
5.7B
6.4B
SHAREHOLDERS' EQUITY
-138.7M
-138.7M
-128.4M
-192.2M
-192.2M
-89.6M
0.0
2K
2K
2K
67K
67K
66K
42K
2.4B
2.4B
2.3B
2.3B
2.3B
2.5B
1.3B
-2.4B
-2.1B
-499.3M
-347.8M
225.1M
117M
637.6M
-4.2M
-5.1M
-11.8M
0.0
0.0
0.0
0.0
-173.9M
84M
1.7B
1.8B
2.3B
2.6B
2B
-167.2M
84M
1.7B
1.8B
2.3B
2.6B
2B
6.7M
0.0
0.0
0.0
0.0
0.0
0.0
SUMMARY
4.9B
5.2B
7B
7.4B
8.2B
8.3B
8.4B
0.0
15M
0.0
0.0
0.0
0.0
0.0
4.6B
4.5B
4.6B
4.8B
4.9B
4.6B
5.4B
4.6B
4.5B
4.5B
4.4B
4.7B
4.5B
5.4B
16,474,835
16,474,835
16,474,835
16,474,835
16,474,835
16,474,835
16,474,835

SEC Filings

CTEV - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 18, 2026
May 18, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 07, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 07, 2026
May 07, 2026
2026
8-K

8-K 2026

N/A

April 30, 2026
April 29, 2026
2026
DEF 14A

DEF 14A 2026

N/A

March 20, 2026
April 29, 2026
2026
8-K

8-K 2026

N/A

March 16, 2026
March 16, 2026
2026
10-K

10-K 2025 FY

FY

February 26, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 23, 2026
February 23, 2026
2026
8-K

8-K 2026

N/A

January 15, 2026
January 15, 2026
2026
8-K

8-K 2025

N/A

December 29, 2025
December 23, 2025
2025
Showing 1 to 10 of 138 filings